Literature DB >> 34422588

Prognostic evaluation model for papillary thyroid cancer: a retrospective study of 660 cases.

Yi-Ming Cao1,2, Ting-Ting Zhang1,2, Bao-Yuan Li3, Ning Qu1,2, Yong-Xue Zhu1,2.   

Abstract

BACKGROUND: Prognostic evaluation model for papillary thyroid cancer is very important for guiding the personalized treatment and follow-up strategy. There are imperfections in the system existed, and there is no suitable prognostic model for Chinese population.
METHODS: This study was based on the clinic and follow-up data of 660 patients received surgical treatments in the Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center from 2000 to 2005. Cox univariate/multivariate analysis was used to explore the influence factors of prognosis, and nomogram model was performed to establish a prognostic prediction system.
RESULTS: Totally, 660 patients for initial treatment were included in our analysis with a median follow-up of 113.5 months. Five-, 10- and 15-year disease-free survival rate was 95.5%, 90.2% and 89.2%. Five-, 10- and 15-year overall survival rate was 99.7%, 99.2% and 99.1%. Residual tumor was associated with overall survival [hazard ratio (HR) 20.9, 95% confidence interval (CI): 2.3-187.6, P<0.05]. Age of onset (HR 2.00, 95% CI: 1.17-3.42, P<0.05) and the dimension of lymph nodes involved (0.2-3 cm: HR 3.67, 95% CI: 1.13-11.87, P<0.05; >3 cm: HR 5.20, 95% CI: 1.31-20.65, P<0.05) were independent influence factors of disease-free survival. The nomogram model for predicting prognosis of papillary thyroid cancer was established with a moderate predictive value (c-index 0.71, 95% CI: 0.57-0.84).
CONCLUSIONS: The prognosis of papillary thyroid cancer is very good after appropriate treatment. Age and the dimension of lymph nodes involved were independent influence factors of disease-free survival for papillary thyroid cancer. A prognostic prediction model for Chinese population was established with moderate predictive value. A study with larger samples and including more factors of prognosis is necessary to increase the predictive value of model. 2021 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Papillary thyroid cancer (PTC); prognostic factors; prognostic prediction model; retrospective study

Year:  2021        PMID: 34422588      PMCID: PMC8340348          DOI: 10.21037/gs-21-100

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  18 in total

Review 1.  How to build and interpret a nomogram for cancer prognosis.

Authors:  Alexia Iasonos; Deborah Schrag; Ganesh V Raj; Katherine S Panageas
Journal:  J Clin Oncol       Date:  2008-03-10       Impact factor: 44.544

2.  Thyroid cancer incidence among Asian immigrants to Ontario, Canada: A population-based cohort study.

Authors:  Baiju R Shah; Rebecca Griffiths; Stephen F Hall
Journal:  Cancer       Date:  2017-04-25       Impact factor: 6.860

3.  New clinical features of thyroid cancer in eastern China.

Authors:  J Xiang; Y Wu; D S Li; Q Shen; Z Y Wang; T Q Sun; Y An; Q Guan
Journal:  J Visc Surg       Date:  2010-03-19       Impact factor: 2.043

4.  The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.

Authors:  Stephen B Edge; Carolyn C Compton
Journal:  Ann Surg Oncol       Date:  2010-06       Impact factor: 5.344

5.  Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989.

Authors:  I D Hay; E J Bergstralh; J R Goellner; J R Ebersold; C S Grant
Journal:  Surgery       Date:  1993-12       Impact factor: 3.982

6.  International patterns and trends in thyroid cancer incidence, 1973-2002.

Authors:  Briseis A Kilfoy; Tongzhang Zheng; Theodore R Holford; Xuesong Han; Mary H Ward; Andreas Sjodin; Yaqun Zhang; Yana Bai; Cairong Zhu; Grace L Guo; Nathaniel Rothman; Yawei Zhang
Journal:  Cancer Causes Control       Date:  2008-11-19       Impact factor: 2.506

7.  Risk factors contributing to a poor prognosis of papillary thyroid carcinoma: validity of UICC/AJCC TNM classification and stage grouping.

Authors:  Yasuhiro Ito; Akira Miyauchi; Tomoo Jikuzono; Takuya Higashiyama; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kiyoshi Ichihara; Kanji Kuma
Journal:  World J Surg       Date:  2007-04       Impact factor: 3.352

8.  Prognostic factors in differentiated thyroid cancer--a 20-year surgical outcome study.

Authors:  Aleksander Konturek; Marcin Barczyński; Wojciech Nowak; Piotr Richter
Journal:  Langenbecks Arch Surg       Date:  2012-02-15       Impact factor: 3.445

9.  Survival in Papillary Thyroid Microcarcinoma: A Comparative Analysis Between the 7th and 8th Versions of the AJCC/UICC Staging System Based on the SEER Database.

Authors:  Fan Yang; Qi Zhong; Zhigang Huang; Meng Lian; Jugao Fang
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-24       Impact factor: 5.555

10.  Creating Prognostic Systems for Well-Differentiated Thyroid Cancer Using Machine Learning.

Authors:  Charles Q Yang; Lauren Gardiner; Huan Wang; Matthew T Hueman; Dechang Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2019-05-08       Impact factor: 5.555

View more
  2 in total

1.  Development of a Risk Predictive Model for Evaluating Immune Infiltration Status in Invasive Thyroid Carcinoma.

Authors:  Runming Pang; Chunxin Qin
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-03       Impact factor: 2.650

2.  An ultrasound model for predicting recurrence of papillary thyroid carcinoma after complete endoscopic resection.

Authors:  Bin Lu; Yibo Zhou; Xiaofeng Lu; Wenchao Weng; Shengye Wang; Jianlin Lou
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2022-05-26       Impact factor: 1.627

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.